Depsipeptide to Treat Patients With Cutaneous T-Cell Lymphoma and Peripheral T-Cell Lymphoma
This study has been completed.
National Cancer Institute (NCI)
First Posted: December 18, 2000
Last Update Posted: May 16, 2017
Information provided by (Responsible Party):
James Gulley, M.D., National Institutes of Health Clinical Center (CC)